Skip to content

Clinical trials

Completed Mental Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Status: Completed Country / region: United Kingdom Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20101
20121
20133
20141
20161
20172
20182
20191
20204
20214
20227
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King's College London7
University of Oxford3
GlaxoSmithKline2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
East Suffolk and North Essex NHS Foundation Trust1
H. Lundbeck A/S1
Hoffmann-La Roche1
Imperial College London1
Inmune Bio, Inc.1
Lancaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders33
Depressive Disorder5
Bipolar Disorder4
Mood Disorders4
Nervous System Diseases4
Schizophrenia4
Alzheimer Disease3
Cognitive Dysfunction3
Dementia3
Alcoholism2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.